United Therapeutics buy UBS Group AG
Start price
08.07.24
/
50%
€292.80
Target price
08.07.25
€341.51
Performance (%)
-17.42%
Price
13:36
€241.80
This prediction will end soon
Summary
This prediction is currently active. The price of United Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.42%. This prediction currently runs until 08.07.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -1.294% | -1.294% |
| iShares Core DAX® | 2.339% | -0.341% |
| iShares Nasdaq 100 | 2.017% | 2.510% |
| iShares Nikkei 225® | 4.496% | 3.027% |
| iShares S&P 500 | 1.174% | 1.353% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $300.00 to $370.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
-0.94%
13:36
13:36
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
-31.94%
13:36
13:36